Grassley Probe: Pharma Provides 81% of NAMI Income
The $$$ amounts–one might call them, "fees for services rendered"–reveal the truth about who wields the greatest influence on NAMI policies–and whose interests are being served by NAMI.
-
-
How to Stop Epidemic Antipsychotic Drug Prescribing
AHRP PROPOSAL:
Any FDA-approved drug, whose manufacturer has been found by a court of law or the Department of Justice–to have illegally marketed the drug by concealing risks or incidence of adverse effects, or making unsupported claims of clinical benefit–should be denied coverage by taxpayer funded insurance programs–including Medicaid, Medicare, VeteranstAffairs. -
Indian Tribe Wins Limit onIts DNA Research
"Did you have permission to use Havasupai blood for your research?" At the heart of this case is a conflict of interests between scientists at powerful institutions that stand to profit from DNA research and powerless members of an underclass.
-
Conflict of Interest | Corporate-Corrupted Medicine | Corrupt Practices | Corrupted Science | Pharma Corrupt Influence
Scoop Interview: Vera Sharav — Peer Review “Fig Leaf”
1 April 2010 The Peer Review “Fig Leaf”: Vera Hassner Sharav By SUZAN MAZUR While the chief of the US National Institute of Mental Health this week stopped short of saying scientists are corrupt because of their ties to industry, as AP reported — Vera Hassner Sharav does not…
-
Rotavirus vaccine found contaminated–FDA Suspends Use of Rotarix
On March 22, 2010 the FDA recommended suspension in the use of GlaxoSMithKline’s Rotarix vaccine–to prevent rotavirus (diarrhea)–due to contamination with pig virus. Rotarix, one of two vaccines licensed in the U.S , has already been given to about 1 million U.S. children along with 30 million worldwide.
-
Specific Anticonvulsants Increase Suicide Risk
A large-scale Harvard meta-analysis published in the Journal of the American Medical Association, is the first ever to evaluate the relationship between different anticonvulsant drugs and the risk of suicide in for patients with diverse diagnoses: " the risk was derived from the specific drug that the patient was taking and not their underlying conditions."
-
Corrupted Science–BMJ Review Examines Avandia Literature
Dr Mark Stolar, professor of clinical medicine at Northwestern: "There are very few people in whom I don’t detect bias based on where their conflicts lie.”
-
In Medicine, the Power of No vs. Psychiatry’s Mass Overtreatment
Unlike patients in other fields of medicine, those who are designated mentally ill–or even declared to be "at risk" for mental illness in the future–are at once stigmatized and suffer losss of their autonomy.
-
AHRP Complaint Results in Research Protocol Change
"OHRP shared your concerns and discussed them with the National Heart Lung and Blood Institute. They appreciated the concerns and have revised the protocol to address them."
-
An Educator Asks: Is Psychiatry a Disorder in Need of Treatment?
An educator with an insightful sense of humor calls psychiatry’s proclivity to designate all manner of human behavior as pathological–an affront.
-
Fig Leaf Reviews and Closed APA Sessions_ScoopNews
Dr. Charles Schulz is scheduled to present "How to help parents of a first psychotic episode patient," at Annual APA Meeting –it is closed to public. What is it that psychiatrists and the APA do not want parents or the public to know?
-
FDA Approves Crestor Use for Healthy People–Watch Healthcare Costs Skyrocket
"500 people would need to be treated with Crestor for a year to avoid one usually survivable heart attack. Stroke numbers were similar…At $3.50 a pill, the cost of prescribing Crestor to 500 people for a year would be $638,000 to prevent one heart attack."
